Stable Antibody-Producing Murine Hybridomas
- 11 March 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 219 (4589) , 1228-1230
- https://doi.org/10.1126/science.6402815
Abstract
A method is described for obtaining antibody-producing hybridomas that are preferentially retained in cultures of fused mouse spleen and myeloma cells. Hybridomas are produced by fusing mouse myeloma cells that are deficient in adenosine phosphoribosyltransferase (APRT) with mouse spleen cells containing Robertsonian 8.12 translocation chromosomes. The cell fusion mixtures are exposed to a culture medium that can be utilized only by APRT-positive cells, which results in the elimination of both unfused APRT-deficient myeloma cells and non-antibody-producing APRT-deficient hybridomas that arise by segregation of the 8.12 translocation chromosomes containing the APRT genes and the active heavy chain immunoglobulin gene.This publication has 15 references indexed in Scilit:
- Monoclonal AntibodiesNew England Journal of Medicine, 1981
- Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains.The Journal of Experimental Medicine, 1981
- Why Hybridomas?Hybridoma, 1981
- Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains.The Journal of Experimental Medicine, 1980
- Status of the linkage map of the mouseCytogenetic and Genome Research, 1978
- Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusionEuropean Journal of Immunology, 1976
- Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell linesEuropean Journal of Immunology, 1976
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Stability of X Chromosomal Inactivation in Human Somatic CellsNature, 1972
- Selection of Hybrids from Matings of Fibroblasts in vitro and Their Presumed RecombinantsScience, 1964